- Home
- COHU vs TNGX Comparison
COHU vs TNGX Comparison
Compare COHU & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COHU
- TNGX
- Stock Information
- Founded
- COHU 1947
- TNGX 2014
- Country
- COHU United States
- TNGX United States
- Employees
- COHU N/A
- TNGX N/A
- Industry
- COHU Electrical Products
- TNGX Biotechnology: Pharmaceutical Preparations
- Sector
- COHU Industrials
- TNGX Health Care
- Exchange
- COHU Nasdaq
- TNGX Nasdaq
- Market Cap
- COHU 885.9M
- TNGX 723.2M
- IPO Year
- COHU N/A
- TNGX N/A
- Fundamental
- Price
- COHU $20.86
- TNGX $6.92
- Analyst Decision
- COHU Buy
- TNGX Strong Buy
- Analyst Count
- COHU 6
- TNGX 6
- Target Price
- COHU $28.20
- TNGX $10.40
- AVG Volume (30 Days)
- COHU 411.6K
- TNGX 1.8M
- Earning Date
- COHU 07-31-2025
- TNGX 08-05-2025
- Dividend Yield
- COHU N/A
- TNGX N/A
- EPS Growth
- COHU N/A
- TNGX N/A
- EPS
- COHU N/A
- TNGX N/A
- Revenue
- COHU $393,941,000.00
- TNGX $24,296,000.00
- Revenue This Year
- COHU $10.84
- TNGX N/A
- Revenue Next Year
- COHU $14.84
- TNGX N/A
- P/E Ratio
- COHU N/A
- TNGX N/A
- Revenue Growth
- COHU N/A
- TNGX N/A
- 52 Week Low
- COHU $12.57
- TNGX $1.03
- 52 Week High
- COHU $29.42
- TNGX $12.02
- Technical
- Relative Strength Index (RSI)
- COHU 58.78
- TNGX 61.95
- Support Level
- COHU $18.92
- TNGX $6.27
- Resistance Level
- COHU $21.36
- TNGX $7.15
- Average True Range (ATR)
- COHU 0.82
- TNGX 0.53
- MACD
- COHU 0.19
- TNGX -0.05
- Stochastic Oscillator
- COHU 79.78
- TNGX 83.33
About COHU Cohu Inc.
Cohu Inc is a supplier of semiconductor test and inspection handlers, micro-electro-mechanical system (MEMS) test modules, test contactors, and thermal sub-systems used by semiconductor manufacturers and test subcontractors. The company's products include Semiconductor ATE (Automated Test Equipment), Semiconductor Handlers, Interface Products such as test contactors, probe heads and probe pins, Spares and Kits, Bare Board PCB Test Systems, and services. It has one reportable segment, Semiconductor Test and Inspection Equipment (Semiconductor Test & Inspection).
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.